This year’s Tour departs from Barcelona in July and while Healy says he hasn’t looked at the 2026 route yet, he does dream ...

Levi Garraway, Roche's chief medical officer and head of global product development. Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 ...

There's only hours to go until we forget all about the 2025 pro cycling season. But before we plunge ourselves ...

Visma-Lease a Bike’s Matthew Brennan really took the cycling world by storm this year. The Brit won four days in a row at the ...

Boxing Day is finally here, marking the last major sales event of the year. With the next one not for months, this is your ...

A professional cycling career is all-consuming, but what happens when the races, money, and routine disappear? Cyclingnews goes inside the transition to the 'real world', and how retirees battle ident ...

A long-time University City resident is expressing concern about updates to the community plan that call for adding bike lanes to a busy thoroughfare.

Ever wondered if Roche Holding is trading at a bargain or a premium? You are not alone, especially with all the chatter about big pharma valuations these days. The stock has shown some real momentum, ...

Roche reported positive Phase III results on trials of its new multiple sclerosis (MS) drug today. Fenebrutinib appears effective at treating both relapsing multiple sclerosis and primary progressive ...

Wondering if Roche Holding might be a hidden gem in today’s market? You’re not alone, as many investors are taking a closer look at what makes this pharmaceutical giant’s stock interesting right now.

This week, the Broad Institute gene-sequencing lab said it read infants’ DNA genomes in less than four hours, cutting an hour off the previous Guinness World Record. The point for investors is that ...

Roche Holding AG will move an experimental obesity shot into late-stage trials next year in a bid to challenge leaders in the booming market for weight-loss medicines. The drug, known as CT-388, ...